Skip to main content
SpringerLink
Log in

Anticancers

Various toxicities and lack of efficacy: 21 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Kwan TT, et al. Preexisting TP53 -Variant Clonal Hematopoiesis and Risk of Secondary Myeloid Neoplasms in Patients with High-grade Ovarian Cancer Treated with Rucaparib. JAMA Oncology 7: 1772-1781, No. 12, Dec 2021. Available from: URL: http://oncology.jamanetwork.com/journal.aspx

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anticancers. Reactions Weekly 1926, 49 (2022). https://doi.org/10.1007/s40278-022-24327-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-24327-2

Search

Navigation